2nd Quarter - Amendment

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,940,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2018 $1,940,000 Replaced
2nd Quarter - Amendment (this page) Jul 25, 2018 $1,940,000 Replaced
2nd Quarter - Amendment Oct 21, 2018 $1,950,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill Trans-Atlantic trade & Investment Partnership Canada IP/Trade Issues South Africa IP Issues China IP Indonesia IP Thailand IP Korea Pricing Issues United Nations Health Panel G7/G20 APEC OECD Australia Market - Size Damages WTO "Zero for Zero" Pharmaceutical Agreement NAFTA

LobbyistCovered position, as disclosed
DOUGLAS REID GOUDIE —

Contacted: Food & Drug Administration (FDA); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Treasury, Dept of; White House Office; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO); Office of the Vice President of the United States; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Biosimilar pass-through

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Treasury, Dept of; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Patent & Trademark Office (PTO); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; White House Office; Natl Security Council (NSC)

Budget/Appropriations BUD

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Economic Council (NEC); SENATE; Treasury, Dept of; Office of the Vice President of the United States; Commerce, Dept of (DOC); Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Copyright/Patent/Trademark CPT

Creates Act Patent Settlements Transferable exclusivity

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); Natl Security Council (NSC); Patent & Trademark Office (PTO); White House Office; Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Treasury, Dept of; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: White House Office; State, Dept of (DOS); Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Treasury, Dept of; Commerce, Dept of (DOC); Office of the Vice President of the United States; U.S. Trade Representative (USTR); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —

Contacted: Commerce, Dept of (DOC); SENATE; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Natl Security Council (NSC); White House Office; Natl Economic Council (NEC); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Food & Drug Administration (FDA)

Health Issues HCR

Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Natl Economic Council (NEC); State, Dept of (DOS); White House Office; Office of the Vice President of the United States; Commerce, Dept of (DOC); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.